Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Revenue by Segment

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Nutritional		13.78B	11.41B	12.36B	11.94B	8.53B
Nutritional Growth		20.77%	-7.69%	3.58%	39.92%	37.53%
Others		1.72B	1.50B	1.27B	1.31B	727.25M
Others Growth		14.36%	18.06%	-2.83%	80.27%	5.62%
Pharmaceutical		46.14B	37.78B	31.49B	30.13B	23.88B
Pharmaceutical Growth		22.11%	20.00%	4.51%	26.18%	12.62%
Diagnostic		6.54B	4.77B	4.13B	3.80B	2.15B
Diagnostic Growth		36.91%	15.53%	8.66%	77.12%	4.14%
Total		68.18B	55.48B	49.26B	47.18B	35.28B
Total Growth		22.90%	12.62%	4.40%	33.72%	17.00%

Revenue by Geography

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pakistan		65.42B	53.22B	47.20B	40.51B	33.52B
Pakistan Growth		22.91%	12.76%	16.52%	20.85%	20.91%
Afghanistan		1.46B	994.09M	797.45M	1.19B	1.12B
Afghanistan Growth		47.02%	24.66%	-32.97%	6.64%	-11.52%
Sri Lanka		35.92M	97.68M	36.02M	38.78M	55.79M
Sri Lanka Growth		-63.22%	171.19%	-7.12%	-30.49%	-19.93%
Bangladesh		60.13M	-	48.76M	-	22.51M
Bangladesh Growth		-	-	-	-	-33.28%
Switzerland		1.20B	1.16B	1.17B	829.03M	567.13M
Switzerland Growth		3.61%	-1.16%	41.42%	46.18%	-46.79%
Total		68.18B	55.48B	49.26B	42.57B	35.28B
Total Growth		22.90%	12.62%	15.71%	20.65%	17.00%

Source: S&P Global Market Intelligence.